Chronic Hepatitis B

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

EMA approval · 2026-07-22
EMA Authorised: Zeffix (lamivudine) — GlaxoSmithKline Trading Services Limited
Zeffix (lamivudine) has been authorised by EMA for chronic hepatitis B.